Skip to main content

NORTRIPTYLINE

Tracking # 20-814017

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

NORTRIPTYLINE IS INDICATED FOR USE IN THE TREATMENT OF DEPRESSION (FDA-APPROVED). IT CAN ALSO BE USED OFF-LABEL FOR CONDITIONS SUCH AS CHRONIC PAIN, DIABETIC NEUROPATHY, MYOFASCIAL PAIN, OROFACIAL PAIN, POSTHERPETIC NEURALGIA. NORTRIPTYLINE HAS ALSO SHOWN TO BE USEFUL IN PATIENTS TRYING TO QUIT SMOKING. NORTRIPTYLINE IS NOT FDA APPROVED FOR USE IN CHILDREN. THIS ACTIVITY COVERS NORTRYPTYLINE, INCLUDING MECHANISM OF ACTION, PHARMACOLOGY, ADVERSE EVENT PROFILES, ELIGIBLE PATIENT POPULATIONS, CONTRAINDICATIONS, MONITORING, AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF NORTRIPTYLINE THERAPY.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I